Access to medicines through global health diplomacy

Vijay Kumar Chattu ^1,2,3 * , Bawa Singh ⁴ , Sanjay Pattanshetty ⁵ , Srikanth Reddy ^6,7

Cited by CrossRef: 8

1- JENEI K. The Political Economy of the World Health Organization Model Lists of Essential Medicines. Milbank Quarterly. 2025;103(1):52 [Crossref]

2- Nirmal P, Singh N, Singh R. Challenges and Opportunities in the Development of Nano-Structured Lipid Carriers for Brain Targeting. ijnrph. 2025;:87 [Crossref]

3- Seretis S, Mavroudeas S, Aksu Tanık F, Benos A, Kondilis E. COVID-19 Pandemic and Vaccine Imperialism. Review of Radical Political Economics. 2025;57(1):9 [Crossref]

4- Harvey N, Al-Daghri N, Beaudart C, Brandi M, Burlet N, Campusano C, Cavalier E, Chandran M, Cooper C, Dawson-Hughes B, Halbout P, Hough T, Lazaretti-Castro M, Matijevic R, Mithal A, Njeze N, Rizzoli R, Saleh Y, Kanis J, Ward K, McCloskey E. Barriers and solutions for global access to osteoporosis management: a Position Paper from the International Osteoporosis Foundation. Osteoporos Int. 2025; [Crossref]

5- Mendis S, Graham I. Prevention and control of cardiovascular disease in “real-world” settings: sustainable implementation of effective policies. Front Cardiovasc Med. 2024;11 [Crossref]

6- Bilousova N, Tkachenko N, Kozhuharyova N, Dolzhenko M. Research of affordability to essential medicines for coronary heart disease in Ukraine. Journal of Pharmaceutical Policy and Practice. 2025;18(1) [Crossref]

7- Petro E, Joosse I, Siebers A, Martopullo T, Hart R, Mantel-Teeuwisse A, van den Ham H, Suleman F. Time and cost involved in measuring access to medicines: the case of Albania. BMC Res Notes. 2025;18(1) [Crossref]

8- Tsuladze A, Zoidze A, Kotrikadze N, Stauke J, Gotsadze G. Breaking barriers to universal health coverage: Insights from Georgia’s chronic disease medicine program. SSM - Health Systems. 2025;5:100129 [Crossref]

9- Osigbesan A, Amamilo I, Solanki A, Matiru R, Conroy J, Omar A, Hatzold K, Amole C, Onasanya K, Ginnard J. The early market access vehicle – An innovative demand-driven model to catalyse introduction of new optimal health products in low- and middle-income countries. Health Policy OPEN. 2025;8:100135 [Crossref]

10- Chattu V, Alla S, Singh B. Political prioritization for digital health and health equity through global health diplomacy. Health Promot Perspect. 2024;14(2):89 [Crossref]

11- Ashiwaju B, Orikpete O, Alade E, Raji A, Adesanya A, Nwankwo T. Impact of Drug Price Regulation on Patient Access to Medicines: A Systematic Review. 2023;7(4):112 [Crossref]

12- Bayked E, Assfaw A, Toleha H, Zewdie S, Biset G, Ibirongbe D, Kahissay M. Willingness to pay for National Health Insurance Services and Associated Factors in Africa and Asia: a systematic review and meta-analysis. Front Public Health. 2024;12 [Crossref]

13- Weldon I, Liddell K, Rogers Van Katwyk S, Hoffman S, Minssen T, Outterson K, Palmer S, Viens A, Viñuales J. Analyzing antimicrobial resistance as a series of collective action problems. Policy Studies Journal. 2024;52(4):833 [Crossref]

14- Twiss E, McPherson C, Weaver D. Global Diseases Deserve Global Solutions: Alzheimer’s Disease. Neurology International. 2025;17(6):92 [Crossref]

15- Kumar Chattu V, Pushkaran A, Narayanan P. Political Prioritization of Access to Medicines and Right to Health: Need for an Effective Global Health Governance Through Global Health Diplomacy Comment on "More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap". Int J Health Policy Manag. 2024;13:8578 [Crossref]

16- Kerek Á, Szabó Á, Jerzsele Á. Antimicrobial Susceptibility Profiles of Salmonella spp. Isolates from Clinical Cases of Waterfowl in Hungary Between 2022 and 2023. Microorganisms. 2024;12(12):2462 [Crossref]

17- Yadav S, Rawal G, Jeyaraman M. India’s Decision to Deny an Extension of Patent for Bedaquiline: A Public Health Imperative. 2023; [Crossref]

18- Singer C, Văruț R, Singer M, Cosoveanu S, Abdul Razzak J, Popescu M, Gaman S, Petrescu I, Popescu C. Epidemiological and Clinical Characteristics of Pediatric Acute Drug Intoxications: A Retrospective Analysis. Children. 2024;12(1):44 [Crossref]

19- Giorgino F, Alzaid F, Pantea Stoian A, Chan J, Ji L, Lumu W, Manrique H, Mauricio D, Saboo B, Senior P, Yabe D, Zoungas S, Meireles M, Mathieu C, Czupryniak L. Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council. Diabetologia. 2025; [Crossref]